Ace Blend bags $9.91M as it looks to scale science-led nutrition
The funding will be used for research-led product development and the launch of patented nutrition formats expected by FY27. Ace Blend focuses on supplements for heart, brain, and immunity health based on clinical evidence. The company reports 300% growth in FY26 and maintains exclusive rights to certain technologies in India.
Key points
- Raised $9.91 million in Series A2 round
- Led by 3one4 Capital with participation from Fireside Ventures
- Focuses on clinically validated nutrition supplements
- Reports 300% growth in FY26
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. YourStory did the reporting; read the original for the full story.
Read the full story at YourStory
